Brucella melitensis Rev. 1 living attenuated vaccine: stability of markers, residual virulence and immunogenicity in mice
- PMID: 1797046
- DOI: 10.1016/s1045-1056(05)80025-9
Brucella melitensis Rev. 1 living attenuated vaccine: stability of markers, residual virulence and immunogenicity in mice
Abstract
Five commercial Brucella melitensis Rev. 1 vaccines from different sources were compared to the original Elberg Rev. 1 strain, in vitro for classic markers and in vivo in mice, for residual virulence and immunogenicity. Because colonies of several morphology types (smooth, non-smooth) were isolated from the vaccines, representative substrains were purified to study their in vitro and in vivo activities either at once (16 strains), or after storage by subculture (12 strains) and by lyophilization (eight strains) or after passage in mice (six strains). After purification, five strains had the characteristic pattern of resistance to penicillin and streptomycin of the original strain while 11 differed by a two-fold dilution or more. A few modifications only occurred after storage or passage. Residual virulence--the time taken by 50% of the subcutaneously vaccinated mice to eradicate the strain from their spleen--or recovery time 50%, and immunogenicity--the ability of the vaccinated mice to restrict the spleen count 15 days after a virulent intraperitoneal challenge--were compared on eight strains after purification, subculture and lyophilization. After purification, one smooth strain out of five had the same activities as the original strain and three were as immunogenic but less virulent. One smooth strain and the three non-smooth were neither immunogenic nor virulent. Some strains which were typically non-smooth after purification recovered a smooth phase aspect after subculture, concomitantly with an increase in immunogenicity but not in virulence.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice.Vaccine. 1990 Oct;8(5):462-8. doi: 10.1016/0264-410x(90)90247-j. Vaccine. 1990. PMID: 2123586
-
In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines.Biologicals. 2000 Jun;28(2):119-27. doi: 10.1006/biol.2000.0249. Biologicals. 2000. PMID: 10885618
-
Transcriptomic analysis of smooth versus rough Brucella melitensis Rev.1 vaccine strains reveals insights into virulence attenuation.Int J Med Microbiol. 2020 Jan;310(1):151363. doi: 10.1016/j.ijmm.2019.151363. Epub 2019 Oct 21. Int J Med Microbiol. 2020. PMID: 31699441
-
[The application and research advances of Brucella vaccines].Wei Sheng Wu Xue Bao. 2006 Oct;46(5):856-9. Wei Sheng Wu Xue Bao. 2006. PMID: 17172046 Review. Chinese.
-
Research progress in live attenuated Brucella vaccine development.Curr Pharm Biotechnol. 2013;14(10):887-96. doi: 10.2174/1389201014666131226123016. Curr Pharm Biotechnol. 2013. PMID: 24372253 Review.
Cited by
-
Use of mass vaccination with a reduced dose of REV 1 vaccine for Brucella melitensis control in a population of small ruminants.Trop Anim Health Prod. 1999 Jun;31(3):135-41. doi: 10.1023/a:1005113412431. Trop Anim Health Prod. 1999. PMID: 10445249
-
Brucella abortus Strain 2308 Wisconsin Genome: Importance of the Definition of Reference Strains.Front Microbiol. 2016 Sep 29;7:1557. doi: 10.3389/fmicb.2016.01557. eCollection 2016. Front Microbiol. 2016. PMID: 27746773 Free PMC article.
-
Protein Biomarker Identification for the Discrimination of Brucella melitensis Field Isolates From the Brucella melitensis Rev.1 Vaccine Strain by MALDI-TOF MS.Front Microbiol. 2021 Oct 22;12:712601. doi: 10.3389/fmicb.2021.712601. eCollection 2021. Front Microbiol. 2021. PMID: 34745025 Free PMC article.
-
Brucella melitensis Rev.1 vaccination generates a higher shedding risk of the vaccine strain in Alpine ibex (Capra ibex) compared to the domestic goat (Capra hircus).Vet Res. 2019 Nov 27;50(1):100. doi: 10.1186/s13567-019-0717-0. Vet Res. 2019. PMID: 31775863 Free PMC article.
-
Deletion of the GI-2 integrase and the wbkA flanking transposase improves the stability of Brucella melitensis Rev 1 vaccine.Vet Res. 2013 Oct 31;44(1):105. doi: 10.1186/1297-9716-44-105. Vet Res. 2013. PMID: 24176078 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources